Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications
- 1 November 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9190) , 1610
- https://doi.org/10.1016/s0140-6736(99)03132-3
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptivesContraception, 1998
- Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control studyThe Lancet, 1997
- Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control studyThe Lancet, 1996
- A multinational case-control study of cardiovascular disease and steroid hormone contraceptivesJournal of Clinical Epidemiology, 1995
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995